Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The association between depressive symptoms and sleep quality in patients with multiple sclerosis: a systematic review and meta-analysis.
Inhibiting fear memory recall-induced oligodendrogenesis rescues PTSD-like behaviors.
18:2 Cholesterol Ester is a Novel Prognostic Biomarker of Disease Progression in Multiple Sclerosis.
Correlation of serum glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells-2 (sTREM-2) levels with disability and clinical characteristics in multiple sclerosis.
The use of routinely collected structural neuroimaging to identify cognitive impairment in multiple sclerosis.
Early Combined B-Cell Depletion and BTK Inhibition Reduced TLS-like Structures and Relapse in PLP-Induced EAE.
Long-term treatment outcomes of immune checkpoint inhibitor-related neuropathies: a French multicenter cohort study.
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.
Quality of life and its influencing factors in patients with neuromyelitis optica spectrum disorder.
Regional patterns of grey matter volume decline in relapsing-remitting multiple sclerosis relative to healthy ageing.
Shared Genomic Architecture Between Schizophrenia and Multiple Sclerosis Identifies an Un-Drugged HCAR1 Neuroimmune Checkpoint.
Reasons for introducing self-intermittent urinary catheterization and long-term outcomes in individuals with multiple sclerosis: a retrospective study.
TRPV1 Agonist Capsaicin Enhances Oxidative-Stress Resistance and Regeneration in Dorsal Root Ganglia and Schwann Cells.
Gray Matter Damage and Long-Term Disability, Cognitive Outcome, and Survival in Patients With Multiple Sclerosis.
Unilateral facial flushing and anhidrosis: a case of idiopathic Harlequin syndrome with successful botulinum toxin treatment.
Case Report: Multiple sclerosis and Neurofibromatosis type 1: a rare comorbidity.
Family planning and multiple sclerosis - part 2: Does real-world practice align with Swedish treatment guidelines?
Evaluation of Dried Plasma Spot-Based Quantification of Glial Fibrillary Acidic Protein as a Disease-Associated Biomarker in Neuromyelitis Optica Spectrum Disorder.
Unusual Sequential Development of Multiple Sclerosis, Thymoma, Myasthenia, and Lymphoma in the Same Patient.
Anti-CD20 associated enterovirus meningoencephalitis: A narrative review with two illustrative cases.
Subcutaneous Ocrelizumab for the Treatment of Relapsing Forms of Multiple Sclerosis: A Budget Impact Model.
Association between peripheral blood T cell subsets and clinical disability in multiple sclerosis patients.
Characteristics of glioma in L-2-Hydroxyglutaric Aciduria: a case report and literature review.
Disease characteristics of SEPSECS deficiency: an international, retrospective, multicenter cohort study.
Real-life walking speed: A new marker of progression in a primary progressive multiple sclerosis cohort study?

Pages